Literature DB >> 31061751

Acute Gaucher Disease-Like Condition in an Indian Infant with a Novel Biallelic Mutation in the Prosaposin Gene.

Akella Radha Rama Devi1, Srilatha Kadali1, Ananthaneni Radhika2, Vineeta Singh3, M Aravind Kumar2, Gummadi Maheshwar Reddy1, Shaik Mohammad Naushad1.   

Abstract

This is the first reported case of prosaposin ( PSAP ) mutation from India manifesting as an acute neuronal Gaucher disease-like condition. A 2-month-old male baby presented with encephalopathy, resistant tonic-clonic seizures, moderate hepatosplenomegaly, hypotonia, and cherry red spot in the retinae. The child had anemia, thrombocytopenia, elevated chitotriosidase, and normal activity of acid sphingomyelinase and low normal activity of β-glucosidase 1 (β-glucocerebrosidase 1, GBA). The child succumbed in the fourth month of life due to persistent respiratory distress and refractory seizures. The clinical phenotype, cherry red spots, elevated chitotriosidase, and lysosomal assays led to the suspicion of Gaucher disease. Exome sequencing revealed a homozygous stop codon mutation in the PSAP gene (c.G1228T, p.Glu410ter). Prenatal diagnosis in the next pregnancy revealed a carrier fetus, who was unaffected postnatally. The diagnosis of specific activator deficiency such as saposin C and saposin D deficiency (in the current study) should be considered and tested for when Gaucher disease is suspected in an infant with partially deficient or near normal GBA activity.

Entities:  

Keywords:  neuronopathic Gaucher disease; prosaposin; specific activator deficiency

Year:  2018        PMID: 31061751      PMCID: PMC6499618          DOI: 10.1055/s-0038-1675372

Source DB:  PubMed          Journal:  J Pediatr Genet        ISSN: 2146-460X


  29 in total

1.  A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation.

Authors:  H Hulková; M Cervenková; J Ledvinová; M Tochácková; M Hrebícek; H Poupetová; A Befekadu; L Berná; B C Paton; K Harzer; A Böör; F Smíd; M Elleder
Journal:  Hum Mol Genet       Date:  2001-04-15       Impact factor: 6.150

2.  A new fluorimetric enzyme assay for the diagnosis of Niemann-Pick A/B, with specificity of natural sphingomyelinase substrate.

Authors:  O P van Diggelen; Ya V Voznyi; J L M Keulemans; K Schoonderwoerd; J Ledvinova; E Mengel; M Zschiesche; R Santer; K Harzer
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

3.  Saposin C mutations in Gaucher disease patients resulting in lysosomal lipid accumulation, saposin C deficiency, but normal prosaposin processing and sorting.

Authors:  Anna M Vaccaro; Marialetizia Motta; Massimo Tatti; Susanna Scarpa; Laura Masuelli; Meenakshi Bhat; Marie T Vanier; Anna Tylki-Szymanska; Rosa Salvioli
Journal:  Hum Mol Genet       Date:  2010-05-19       Impact factor: 6.150

4.  Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease.

Authors:  D Schnabel; M Schröder; K Sandhoff
Journal:  FEBS Lett       Date:  1991-06-17       Impact factor: 4.124

5.  Combined saposin C and D deficiencies in mice lead to a neuronopathic phenotype, glucosylceramide and alpha-hydroxy ceramide accumulation, and altered prosaposin trafficking.

Authors:  Ying Sun; David P Witte; Matt Zamzow; Huimin Ran; Brian Quinn; Junko Matsuda; Gregory A Grabowski
Journal:  Hum Mol Genet       Date:  2007-03-12       Impact factor: 6.150

6.  A mutation within the saposin D domain in a Gaucher disease patient with normal glucocerebrosidase activity.

Authors:  Anna Diaz-Font; Bru Cormand; Raül Santamaria; Lluïsa Vilageliu; Daniel Grinberg; Amparo Chabás
Journal:  Hum Genet       Date:  2005-04-23       Impact factor: 4.132

7.  Apparent diffusion coefficient vale of the brain in patients with Gaucher's disease type II and type III.

Authors:  Ahmed Abdel Khalek Abdel Razek; Nahed Abd El-Gaber; Ahmed Abdalla; Abeer Fathy; Ahmed Azab; Ashraf Abdel Rahman
Journal:  Neuroradiology       Date:  2009-07-15       Impact factor: 2.804

8.  Mutation in saposin D domain of sphingolipid activator protein gene causes urinary system defects and cerebellar Purkinje cell degeneration with accumulation of hydroxy fatty acid-containing ceramide in mouse.

Authors:  Junko Matsuda; Makiko Kido; Keiko Tadano-Aritomi; Ineo Ishizuka; Kumiko Tominaga; Kazunori Toida; Eiji Takeda; Kunihiko Suzuki; Yasuhiro Kuroda
Journal:  Hum Mol Genet       Date:  2004-09-02       Impact factor: 6.150

9.  Non-neuronopathic Gaucher disease due to saposin C deficiency.

Authors:  A Tylki-Szymańska; B Czartoryska; M-T Vanier; B J M H Poorthuis; J A E Groener; A Ługowska; G Millat; A M Vaccaro; E Jurkiewicz
Journal:  Clin Genet       Date:  2007-10-07       Impact factor: 4.438

10.  Specific saposin C deficiency: CNS impairment and acid beta-glucosidase effects in the mouse.

Authors:  Ying Sun; Huimin Ran; Matt Zamzow; Kazuyuki Kitatani; Matthew R Skelton; Michael T Williams; Charles V Vorhees; David P Witte; Yusuf A Hannun; Gregory A Grabowski
Journal:  Hum Mol Genet       Date:  2009-12-16       Impact factor: 6.150

View more
  2 in total

1.  Lack of evidence for genetic association of saposins A, B, C and D with Parkinson's disease.

Authors:  Yuri Ludwig Sosero; Sara Bandres-Ciga; Sharon Hassin-Baer; Roy N Alcalay; Ziv Gan-Or
Journal:  Brain       Date:  2020-09-01       Impact factor: 13.501

2.  Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis.

Authors:  Ruilin Tian; Anthony Abarientos; Jason Hong; Sayed Hadi Hashemi; Rui Yan; Nina Dräger; Kun Leng; Mike A Nalls; Andrew B Singleton; Ke Xu; Faraz Faghri; Martin Kampmann
Journal:  Nat Neurosci       Date:  2021-05-24       Impact factor: 28.771

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.